Our results establish a putative link between BCR-ABL1 TK activity-contingent enhancement of CBY1 SUMOylation and inactivation of JNK/14-3-3σ associated with the BCR-ABL1 TK activity of CML. Here, TKT is linked to chronic myelogenous leukemia, BCR-ABL1 positive.